Tianjin Chase Sun Pharmaceutical Co.,Ltd at its Annual General Meeting of 2022 on 24 April 2023, approved the profit distribution proposal of cash dividend (tax included) of CNY 0.30000000 per 10 shares for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.69 CNY | -1.07% | 0.00% | -12.97% |
Mar. 29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
Mar. 01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.97% | 1.53B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
+33.40% | 1.38B | |
+34.29% | 1.3B |
- Stock Market
- Equities
- 300026 Stock
- News Tianjin Chase Sun Pharmaceutical Co.,Ltd
- Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2022